Le Lézard
Classified in: Health
Subjects: CHI, PDT, FDA

Introducing Overjet for Kids: Dental AI that Parents Need


Overjet for Kids helps pediatric dentists more accurately detect tooth decay ? and gives parents a deeper understanding of their children's oral health.

BOSTON, March 13, 2024 /PRNewswire/ -- Overjet, the world-leader in dental AI, today announced the launch of Overjet for Kids: the new standard of dental care for kids. It is the only technology cleared by the U.S. Food and Drug Administration (FDA) to detect, outline, and quantify tooth decay in children ages 4 and above, a critical time to prevent future problems.

100% of dentists were more accurate in detecting cavities when using Overjet for Kids.

Overjet for Kids helps pediatric dentists build a lifetime of trust with patients ? by catching subtle tooth decay in X-rays before children feel pain, and by better explaining their recommendations to parents. In a rigorous clinical study conducted for the FDA, 100% of dentists were more accurate in detecting cavities when using Overjet for Kids, compared to their evaluations without it. The AI is trained to analyze both primary and permanent teeth, which allows Overjet to highlight its findings with colorful outlines that kids and parents can understand.

"Every parent wants to be confident that their child is getting the world's best dental care," said Dr. Teresa Dolan, Overjet's Chief Dental Officer. "But prior to this technology, there was no way for parents to see what a dentist sees in their child's X-ray, which can lead some parents to not understand the problem or even decline necessary treatment. Overjet for Kids empowers them to make truly informed decisions, setting kids up for a lifetime of good oral health."

Early childhood is the most important time to prevent oral diseases, which are correlated with serious long-term health risks, such as cancer and diabetes. Yet more than half of American children between ages 6 and 11 have cavities, according to the U.S. Centers for Disease Control and Prevention (CDC).

Overjet's artificial intelligence provides dentists with the first objective standard that quantifies pathologies like tooth decay, down to the millimeter. In the aforementioned study, dentists missed 57% less cavities when using Overjet, compared to when unassisted by AI. And because Overjet also improves patient education, dental practices that use the tool have increased their overall case acceptance by an average of 25%.

"My favorite thing about Overjet for Kids is the early detection," said Dr. Matt Hicks of The Airway Dentists, an Overjet customer. "If we catch it early, kids can change their habits at home first, before we have to go in and do any irreversible work. And at the same time, our case acceptance has gone up, because parents can just see so much more."

Overjet for Kids relies on groundbreaking clearances from the FDA:

The launch of Overjet for Kids comes at a time of rapid growth and innovation for the company. On March 5, Overjet announced it had raised $53 million of Series C funding, the largest investment in the history of dental AI. This funding will fuel the development of unprecedented products that extend its AI platform to more patients and use cases ? improving oral health for all.

About Overjet

Overjet is the world-leader in dental AI. Founded by experts from MIT and Harvard University, Overjet builds artificial intelligence that helps dental organizations give patients the highest quality of care. Our FDA-cleared technology is the first objective standard for making oral health decisions ? so that dentists can detect pathologies with precision and educate patients with confidence. To learn more, visit: overjet.ai.

Press Contact
Logan Goldberg
Director of Communications, Overjet
Email: [email protected]

SOURCE Overjet


These press releases may also interest you

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...



News published on and distributed by: